GE HealthCare Technologies (GEHC) Expected to Announce Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, April 30th. Analysts expect GE HealthCare Technologies to post earnings of $0.91 per share and revenue of $4.66 billion for the quarter. GE HealthCare Technologies has set its FY 2025 guidance at 4.610-4.750 EPS.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $68.07 on Tuesday. The firm has a market cap of $31.17 billion, a P/E ratio of 15.72, a P/E/G ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The business’s 50 day moving average price is $76.10 and its 200-day moving average price is $81.91. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.21%. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on GEHC shares. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the company a “buy” rating in a research report on Monday, April 14th. Piper Sandler dropped their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price target for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.